Change of Director’s Interest Notice
161213_Change of Director’s Interest Notice
161213_Change of Director’s Interest Notice
151126_GenScript Further Pre-Clinical Validation for Phase II Trial
151124_RedChip appointed to begin Global Investor Relations Program
150812_Change of Director's Interest Notice
151030_Appendix 4C Quarterly Report & Company Update
151027_Results of Annual General Meeting
150401_PharmAust Broker Roadshow Presentation – April 2015
151105_Change of Director's Interest Notice